2,993 results found

Last week the Canadian government announced a more restrictive approach to the review of critical minerals investments under the Investment Canada Act (ICA)...

Yesterday the federal government released guidelines on the national security review of foreign investments in Canada.

The 2024 federal budget released yesterday includes an emphasis on "getting major projects done" with the announcement of several new measures intended to improve federal regulatory and permitting processes.

The Trans Mountain pipeline expansion is a vital strategic interest to Canada. It will be built … We are a vast, varied cooperative federation, built on centuries of compromise.

Twenty years after the introduction of section 11.01, it is clear this provision has failed to live up to the promise of Quintette. Section 11.01 has effectively been replaced by a model order regime.

Retail trade and accommodation and food services were sectors anticipated by many to face the most short-term hardship due to the pandemic.

The 2024 Ontario Fall Economic Statement introduced amendments to the Insurance Act that will require licensing of life and accident & sickness (A&S) managing general agents (MGAs).

It is now possible, under certain circumstances set out in the Regulation respecting categories of insurance contracts and classes of insureds that may derogate from the rules of articles...

The Financial Services Regulatory Authority of Ontario (FSRA), the Ontario insurance regulator, has identified two key areas of assessment of life and health insurers licensed in Ontario for 2020-2021.

On August 9, the Office of the Superintendent of Financial Institutions (OSFI) released draft guidance for reinsurance security agreements (the RSA Guidance), marking a shift away from the use of standard form reinsurance trust agreements.

The USPTO issued preliminary instructions (PTO Guidance) that use a two-part analysis for determining patent-eligible subject matter to its examiners.

On June 12, 2008, amendments to the “Patented Medicines (Notice of Compliance) Regulations” (commonly referred to as the “PM(NOC) Regulations”) came into force.

On July 3, Canada's federal government published proposed amendments to Canada's Patent Rules aimed at streamlining the patent examination

The Federal Court of Canada granted standing to Sanofi-Aventis Canada Inc. in a case involving a Sanofi product on the Register of Innovative Drugs.

The judge-made law of double patenting prevents a patentee from obtaining more than one patent for the same invention, and prohibits claims in a second patent that are not patentably distinct from those of the first patent.

In Janssen Inc. v. Apotex Inc., 2023 FCA 243, the Federal Court of Appeal found that it was an abuse of process for Apotex to challenge the validity of a patent...

In another step towards implementing French language signage rules, the Government of Québec has announced that modifications to the Regulation respecting the language of commerce and business...